NCT01362621
- Conditions
- Moderate to Severe Allergic Asthma
- Locations
-
- Novartis Investigative Site Birmingham, Alabama, United States
- Novartis Investigative Site Crescent City, California, United States
- Novartis Investigative Site Fresno, California, United States
- Novartis Investigative Site Oakland, California, United States